Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options...
Oncolytics Biotech Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to pelareorep in combination with Roche's anti-PD-L1...
Esperovax, a leading developer of oral vaccines, announced it has signed a new, exclusive licensing agreement with Innovation Partners at the University of Michigan...
Cipla Limited and its wholly owned subsidiary Cipla USA Inc. (hereafter referred to as 'Cipla'), announced the launch of Leuprolide Acetate Injection Depot 22.5mg....
